Paul Pagano

Efficacy of Linezolid plus Rifampin in an Experimental Model of Methicillin-Susceptible <i>Staphylococcus aureus</i> Endocarditis

Charlene F. Dailey, Paul Pagano, Lewis V. Buchanan et al. · Antimicrobial Agents and Chemotherapy · 2003 · 37 citations · Full text

Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC

Joseph S. Warmus, Cheryl L. Quinn, Clarke Taylor et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 32 citations · Full text

Biochemistry, Medicine, Rational Drug Design +8

Antibacterial Oxazolidinones Possessing a Novel C-5 Side Chain. (5<i>R</i>)-<i>trans</i>-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic Acid Amide (PF-00422602), a New Lead Compound

Toni‐Jo Poel, Richard C. Thomas, Wade J. Adams et al. · Journal of Medicinal Chemistry · 2007 · 28 citations · Full text

Reverse Amides, Bioorganic Chemistry, Antiparasitic Agent +20

Effects of linezolid on staphylococcal adherence versus time of treatment

Paul Pagano, Lewis V. Buchanan, Charlene F. Dailey et al. · International Journal of Antimicrobial Agents · 2004 · 19 citations

Antimicrobial Susceptibility, Health Sciences, Medicine +7

Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution

Cindy L. Wolfe, Paul Pagano, Chris M. Pillar et al. · Diagnostic Microbiology and Infectious Disease · 2018 · 17 citations · Full text

Antimicrobial Susceptibility, Antibiotics, Clostridium Difficile +10